Braveheart Bio Inc (BRVE) Stock Price, Quote, News & History

BRVENASDAQ
$30.00
0.200.67%
At close: Aug 7, 5:00 PM EST
$31.15
1.153.83%
After Hours: 7:24 PM EST
Loading...

Key Statistics

Open
$29.70
Close
$30.00
Volume / Avg.
566.97K / 3.29M
Day Range
$28.47 - $32.00
52 Wk Range
29.42 - 31.56
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
-

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-7.20M
Investing Cash Flow (TTM)
-36.60M
Financing Cash Flow (TTM)
124.38M
Free Cash Flow (TTM)
-43.81M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-

Valuation Metrics

Enterprise Value
-
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$80.58M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$29.70
Close
$30.00
Volume / Avg.
566.97K / 3.29M
Day Range
$28.47 - $32.00
52 Wk Range
29.42 - 31.56
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
-

About

Sector
N/A
Industry
N/A
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Braveheart Bio (BRVE) stock?

A

You can purchase shares of Braveheart Bio (NASDAQ:BRVE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Braveheart Bio (BRVE) competitors?

A

There are no as such competitors for Braveheart Bio.

Q

What is the forecast, or price target, for Braveheart Bio (BRVE) stock?

A

There is no analysis for Braveheart Bio to provide a consensus price target.

Q

What is the current price for Braveheart Bio (BRVE)?

A

The stock price for Braveheart Bio (NASDAQ: BRVE) is $31.15 last updated August 7, 2026 at 7:24 PM EDT.

Q

Does Braveheart Bio (BRVE) pay a dividend?

A

There are no upcoming dividends for Braveheart Bio.

Q

When is Braveheart Bio (NASDAQ:BRVE) reporting earnings?

A

Braveheart Bio does not have any upcoming earnings scheduled.

Q

Is Braveheart Bio (BRVE) going to split?

A

There is no upcoming split for Braveheart Bio.

Q

What sector and industry does Braveheart Bio (BRVE) operate in?

A

Braveheart Bio is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.